Kersten, M. J., Driessen, J., Zijlstra, J. M., Plattel, W. J., Morschhauser, F., Lugtenburg, P. J., Brice, P., Hutchings, M., Gastinne, T., Liu, R., Burggraaff, C. N., Nijland, M., Tonino, S. H., Arens, A. I., Valkema, R., van Tinteren, H., Lopez-Yurda, M., Diepstra, A., De Jong, D. and Hagenbeek, A. (2021) “Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study”, Haematologica. Pavia, Italy, 106(4), pp. 1129-1137. doi: 10.3324/haematol.2019.243238.